This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ketorolac 30 mg/ml vials. The contract, valued at $1,318.38, is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,124.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4565663726 KETOROLAC 30 MG/ML VIALML, with a period of performance ending on September 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,609.74, is for the delivery of the drug Ketorolac 30 mg/ml in vials. It is a Firm Fixed Price contract that runs through January 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 19, 2023 and a ceiling value of $1,079.06. It is a firm fixed price contract for the procurement of 4563134402 - Ketorolac 30 mg/ml vials. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,454.70, is a delivery order for the supply of ketorolac 30 mg/ml vials. The contract has an ultimate completion date of December 24, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ketorolac 60 mg/2 ml vials. The contract is a Delivery Order valued at $14,133.55 and has a completion date of September 10, 2024. The contract is Firm Fixed Price and is not set aside for any specific business type. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,451.88 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/ml vials, a pharmaceutical product. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up...
This federal contract award, valued at $3,668.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. Amerisourcebergen, a major pharmaceutical distributor, will supply 4565579056 - Ketorolac 15mg/ml in 25-count packages to support the DLA's medical supply requirements. This delivery order contract has an ultimate completion date of August 27, 2024 and utilizes a Firm Fixed Price pricing type. The contract is not...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,020.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,476,985 units of the pharmaceutical product Ketorolac 60 mg/2 ml vial. The contract has a completion date of January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and the parent company is Cencora, Inc., which does business as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,758.90, is a Firm Fixed Price delivery order for the supply of Ketorolac 30 mg/ml vials. The contract has an ultimate completion date of January 17, 2023 and was awarded on January 13, 2023. This award is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...